Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease.

Anders ForssMark ClementsPär MyrelidHans StridCharlotte SödermanAgnieszka WagnerDavid AnderssonFredrik Hjelmnull nullOla OlénJonas HalfvarsonJonas F Ludvigsson

Published in: Digestive diseases and sciences (2022)

In this nationwide prospective real-world 104-week-follow-up study of adult patients with active CD, ustekinumab was associated with long-term clinical effectiveness and improvement in HRQoL measures when used in routine clinical care.

Keyphrases

randomized controlled trial
systematic review
healthcare
palliative care
clinical trial
clinical practice
cross sectional
pain management